Leandra Koletzko
Overview
Explore the profile of Leandra Koletzko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koletzko S, Le Thi T, Zhelyazkova A, Osterman A, Wichert S, Breiteneicher S, et al.
Clin Exp Med
. 2023 Sep;
23(8):4901-4917.
PMID: 37659994
The primary objective of the RisCoin study was to investigate the interplay of genetic, metabolic, and lifestyle factors as well as stress levels on influencing the humoral immune response after...
2.
Koletzko L, Klucker E, Le Thi T, Breiteneicher S, Rubio-Acero R, Neuhaus L, et al.
J Clin Med
. 2021 Sep;
10(18).
PMID: 34575235
Background: COVID-19-associated restrictions impact societies. We investigated the impact in a large cohort of inflammatory bowel disease (IBD) patients. Methods: Pediatric (pIBD) and adult patients and pIBD parents completed validated...
3.
Unterweger A, Ruscher A, Seuss M, Winkelmann P, Beigel F, Koletzko L, et al.
Immun Inflamm Dis
. 2021 Sep;
9(4):1631-1647.
PMID: 34499803
Introduction: Crohn's disease (CD) is characterized by pronounced intestinal fibrosis and severe mucosal damage and conventional animal models are limited to reflect these pathological manifestations. The aim of this study...
4.
Winkelmann P, Unterweger A, Khullar D, Beigel F, Koletzko L, Siebeck M, et al.
Immun Inflamm Dis
. 2021 May;
9(3):804-818.
PMID: 33942546
With glucose being the preferred source of energy in activated T cells, targeting glycolysis has become an attractive therapeutic intervention point for chronic inflammatory bowel diseases (IBD). The switch to...
5.
Unterweger A, Jensen M, Giordanetto F, Jogini V, Ruschher A, Seuss M, et al.
J Crohns Colitis
. 2021 Apr;
15(11):1943-1958.
PMID: 33891001
Background And Aims: The potassium channel Kv1.3 is a potentially attractive therapeutic target in T cell-mediated inflammatory diseases, as the activity of antigen-activated T cells is selectively impeded by Kv1.3...
6.
Macke L, Schulz C, Koletzko L, Malfertheiner P
Aliment Pharmacol Ther
. 2020 Jan;
51(5):505-526.
PMID: 31990420
Background: Proton pump inhibitors (PPI) are widely used to treat acid-related disorders of the upper gastrointestinal tract. However, large observational studies have raised concerns about PPI-associated adverse events. In recent...
7.
Koletzko L, Macke L, Schulz C, Malfertheiner P
Best Pract Res Clin Gastroenterol
. 2019 Oct;
40-41:101637.
PMID: 31594649
A causal relationship between Helicobacter pylori (H. pylori) infection and functional dyspepsia (FD) is well established in a subset of infected patients. In the Kyoto and Maastricht/Florence consensus reports H....
8.
Koletzko L, Mahli A, Hellerbrand C
Pathol Res Pract
. 2018 Sep;
214(10):1700-1706.
PMID: 30201523
Hepatic steatosis is common in patients infected with hepatitis C virus (HCV). Particularly in patients infected with non-genotype 3 HCV, hepatic steatosis is closely related to factors of the metabolic...
9.
Sabel B, Plum J, Kneidinger N, Leuschner G, Koletzko L, Raziorrouh B, et al.
J Cardiovasc Comput Tomogr
. 2017 Mar;
11(3):188-195.
PMID: 28259629
Objectives: To evaluate the effect of structured reporting of CT pulmonary angiography (CTPA) studies on the content, clarity and clinical usefulness of radiology reports in acute pulmonary embolism (PE). Methods:...